ICTR

Harold and Muriel Block
Institute for Clinical and Translational Research at Einstein and Montefiore

Founded on the partnership between Albert Einstein College of Medicine and Montefiore Medical Center, the ICTR has helped cement that collaboration in clinical and translation research since 2007.

The ICTR is a member of the nationwide Clinical and Translational Science Awards (CTSA) consortium, funded by the National Institutes of Health (NIH). The CTSA is designed to break down barriers that inhibit cross-disciplinary, bidirectional research from the laboratory to the clinic and back again.

Descriptions of Cores are located under Services or can be found by hovering over the core bubbles below.





Apply for one of four areas
of funding.

For a searchable list of clinical trials at Einstein-Montefiore, click here.



ICTR Brochure

Download >

The OCT is available to assist PIs and their research teams with budget development as well as negotiations with sponsors/CROs. Should the PI/research team choose to negotiate their own budgets with the sponsor, the following expense items are to be included:

  • Costs for tests and procedures
  • IRB processing fees
  • Institutional Overhead of 35%

Other Montefiore-Einstein fees are applicable in building the budget. OCT personnel will help you identify the proper charge for each of these fees which include but are not limited to:

  • CRC fees
  • OCT fees
  • Pharmacy fees
  • Study site activation charges as needed  

Budgeting FAQs

How do I do a budget if the sponsor has not provided one?
Answer: The OCT Manager assigned to your project will assist you with the creation of a budget.

What format should I use?
Answer: The Office of Clinical Trials has a budget template for your use.

What are direct costs?
Answer: Direct costs are charges for services, time and effort required to perform the work stipulated within a contract and identified with a specific project or program.

What are indirect costs?
Answer: Indirect costs are applied to procedures, tests and work that require time and effort on the part of the research team.

What is our level of institutional overhead expected from sponsors?
Answer: The institutional overhead for all industry supported clinical trials is generally 35%.

Once I have developed the budget, what is my next step?
Answer: When you have developed a budget; send it to the OCT for a final review for any institutional charges that need to be included or any changes that might be required.

Should I also develop payment terms?
Answer: Payment terms are negotiated by OCT.

Click here to log in